{"id":40198,"date":"2023-09-18T21:01:13","date_gmt":"2023-09-18T21:01:13","guid":{"rendered":"https:\/?p=40198"},"modified":"2023-09-18T21:01:13","modified_gmt":"2023-09-18T21:01:13","slug":"moderna-mrnansd-sta-research-maintains-underperform-rating","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/","title":{"rendered":"Moderna (MRNA:NSD) STA Research Maintains &#8220;Underperform&#8221; Rating"},"content":{"rendered":"<h2>Analyst Ratings Coverage<\/h2>\n<p>STA Research<a href=\"https:\/\/www.stocktargetadvisor.com\/Analyst-Ranking\/STA%20Research\">\u00a0(Analyst Rank #29 of #350)<\/a> issued a research report on Moderna Inc., on Monday September 18th, and maintained the \u201cUnderperform\u201d rating on the company\u2019s stock.<\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/MRNA\" target=\"_blank\" rel=\"noopener\">MRNA Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"MRNA\" data-theme=\"wt_bg_light\" data-uid=\"14049914836508ba82184fd6508ba82184fe\" data-width=\"900\" >\n\t\t<\/script><\/p>\n<\/div>\n<h2>MRNA Stock Analysis &amp; Forecast<\/h2>\n<p><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/MRNA\">Moderna Inc,<\/a> a prominent player in the biotechnology and pharmaceutical industry, continues to draw attention from both investors and analysts. Analysts&#8217; forecasts and the recent performance of Moderna&#8217;s stock provide essential insights for those considering investments in the company. In this article, we delve into these aspects to gain a deeper understanding of Moderna&#8217;s position in the market.<\/p>\n<p><strong>Analyst Projections:<\/strong><\/p>\n<p>Based on the consensus of 12 analysts, the average target price for Moderna Inc is USD 148.45 over the next 12 months. This target price reflects a positive outlook for the company&#8217;s stock and suggests potential for substantial growth in the coming year.<\/p>\n<p>Furthermore, the average analyst rating for Moderna Inc is classified as &#8220;Buy.&#8221; This consensus rating indicates that analysts generally view the company&#8217;s stock as an attractive investment option, emphasizing positive sentiment within the financial community.<\/p>\n<p><strong>Stock Target Advisor&#8217;s Analysis:<\/strong><\/p>\n<p><a href=\"https:\/\/www.stocktargetadvisor.com\/\">Stock Target Advisor<\/a>, an independent analysis platform, provides its unique perspective on Moderna Inc&#8217;s stock. Their analysis characterizes the company&#8217;s outlook as &#8220;Slightly Bullish.&#8221; This rating is determined by a combination of 10 positive signals and 5 negative signals identified by their proprietary algorithm.<\/p>\n<p>Positive signals may encompass factors such as strong financial performance, groundbreaking research, or favorable industry dynamics. Conversely, negative signals could include considerations like market volatility or regulatory challenges.<\/p>\n<p><strong>Recent Stock Performance:<\/strong><\/p>\n<p>At the last closing, Moderna Inc&#8217;s stock was valued at USD 114.59. This figure represents the most recent market price for the company&#8217;s shares, reflecting investor sentiment and market dynamics.<\/p>\n<p>Over the past week, the stock price experienced a notable increase, rising by +6.46%. Such short-term fluctuations in stock prices can be influenced by various factors, including market sentiment, company-specific news, or broader economic events.<\/p>\n<p>Over the past month, the stock price continued its upward trajectory, showing a significant gain of +7.86%. This could be influenced by several factors, including positive clinical trial results, increased vaccine distribution, or overall optimism surrounding the biotechnology sector.<\/p>\n<p>Over the last year, however, the stock price has experienced a moderate decline, down by -16.81%. Long-term stock performance can be influenced by various factors, including changes in market sentiment, shifts in healthcare policies, or competitive dynamics.<\/p>\n<p><strong>Stock Analysis Summary:<\/strong><\/p>\n<p><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/MRNA\">Moderna Inc&#8217;s<\/a> stock projections and recent performance in the market offer valuable insights for investors. The average target price of USD 148.45 and a &#8220;Buy&#8221; rating from analysts suggest optimism regarding the company&#8217;s growth potential.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Analyst Ratings Coverage STA Research\u00a0(Analyst Rank #29 of #350) issued a research report on Moderna Inc., on Monday September 18th, and maintained the \u201cUnderperform\u201d rating&#8230;<\/p>\n","protected":false},"author":3,"featured_media":28939,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[10347,10351,10348,10350,10349],"class_list":["post-40198","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-moderna-mrnansd-sta-research-maintains-underperform-rating","tag-mrna-sell","tag-mrna-stock","tag-mrna-stock-analysis","tag-mrna-target"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Moderna (MRNA:NSD) STA Research Maintains &quot;Underperform&quot; Rating | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Moderna (MRNA:NSD) STA Research Maintains &quot;Underperform&quot; Rating\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings Coverage STA Research\u00a0(Analyst Rank #29 of #350) issued a research report on Moderna Inc., on Monday September 18th, and maintained the \u201cUnderperform\u201d rating...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-18T21:01:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/02\/Untitled-design-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"Moderna (MRNA:NSD) STA Research Maintains &#8220;Underperform&#8221; Rating\",\"datePublished\":\"2023-09-18T21:01:13+00:00\",\"dateModified\":\"2023-09-18T21:01:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/\"},\"wordCount\":435,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"keywords\":[\"Moderna (MRNA:NSD) STA Research Maintains \\\"Underperform\\\" Rating\",\"MRNA Sell\",\"MRNA stock\",\"MRNA stock analysis\",\"MRNA target\"],\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/\",\"name\":\"Moderna (MRNA:NSD) STA Research Maintains \\\"Underperform\\\" Rating | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2023-09-18T21:01:13+00:00\",\"dateModified\":\"2023-09-18T21:01:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Moderna (MRNA:NSD) STA Research Maintains &#8220;Underperform&#8221; Rating\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Moderna (MRNA:NSD) STA Research Maintains \"Underperform\" Rating | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/","og_locale":"en_US","og_type":"article","og_title":"Moderna (MRNA:NSD) STA Research Maintains \"Underperform\" Rating","og_description":"Analyst Ratings Coverage STA Research\u00a0(Analyst Rank #29 of #350) issued a research report on Moderna Inc., on Monday September 18th, and maintained the \u201cUnderperform\u201d rating...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2023-09-18T21:01:13+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/02\/Untitled-design-2.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"Moderna (MRNA:NSD) STA Research Maintains &#8220;Underperform&#8221; Rating","datePublished":"2023-09-18T21:01:13+00:00","dateModified":"2023-09-18T21:01:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/"},"wordCount":435,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"keywords":["Moderna (MRNA:NSD) STA Research Maintains \"Underperform\" Rating","MRNA Sell","MRNA stock","MRNA stock analysis","MRNA target"],"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/","name":"Moderna (MRNA:NSD) STA Research Maintains \"Underperform\" Rating | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2023-09-18T21:01:13+00:00","dateModified":"2023-09-18T21:01:13+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/moderna-mrnansd-sta-research-maintains-underperform-rating\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Moderna (MRNA:NSD) STA Research Maintains &#8220;Underperform&#8221; Rating"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/40198","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=40198"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/40198\/revisions"}],"predecessor-version":[{"id":40202,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/40198\/revisions\/40202"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/28939"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=40198"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=40198"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=40198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}